NewslettersMammary Cell NewsUncategorizedSynergistic Targeting of BRCA1 Mutated Breast Cancers with PARP and CDK2 InhibitionBy Justin.choi - August 31, 2021025In cell lines, BRCA1 loss was associated with stabilized cyclin E1 during the cell cycle, and BRCA1 siRNA led to increased cyclin E1 in association with reduced phospho-cyclin E1 T62.[npj Breast Cancer] 7992332 {7992332:LVJ2LSCB} apa 50 1 166258 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article